3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Design and testing of a humanized porcine donor for xenotransplantation

      research-article
      1 , 1 , 1 , 2 , 2 , 1 , 2 , 1 , 1 , 1 , 3 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 2 , 1 , 1 , 2 , 1 , 2 , 1 , 1 , 1 , 1 , 3 , 1 , 1 , 2 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 4 , 5 , 6 , 5 , 4 , 4 , 7 , 2 , 8 , 9 , 1 , 2 , 1 , , 1 ,
      Nature
      Nature Publishing Group UK
      Synthetic biology, Preclinical research

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Recent human decedent model studies 1, 2 and compassionate xenograft use 3 have explored the promise of porcine organs for human transplantation. To proceed to human studies, a clinically ready porcine donor must be engineered and its xenograft successfully tested in nonhuman primates. Here we describe the design, creation and long-term life-supporting function of kidney grafts from a genetically engineered porcine donor transplanted into a cynomolgus monkey model. The porcine donor was engineered to carry 69 genomic edits, eliminating glycan antigens, overexpressing human transgenes and inactivating porcine endogenous retroviruses. In vitro functional analyses showed that the edited kidney endothelial cells modulated inflammation to an extent that was indistinguishable from that of human endothelial cells, suggesting that these edited cells acquired a high level of human immune compatibility. When transplanted into cynomolgus monkeys, the kidneys with three glycan antigen knockouts alone experienced poor graft survival, whereas those with glycan antigen knockouts and human transgene expression demonstrated significantly longer survival time, suggesting the benefit of human transgene expression in vivo. These results show that preclinical studies of renal xenotransplantation could be successfully conducted in nonhuman primates and bring us closer to clinical trials of genetically engineered porcine renal grafts.

          Abstract

          Using kidneys from a genetically engineered porcine donor transplanted into a cynomolgus monkey model, the design, creation and long-term function of kidney grafts supporting life are explored.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: found
          • Article: not found

          Multiplex genome engineering using CRISPR/Cas systems.

          Functional elucidation of causal genetic variants and elements requires precise genome editing technologies. The type II prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats)/Cas adaptive immune system has been shown to facilitate RNA-guided site-specific DNA cleavage. We engineered two different type II CRISPR/Cas systems and demonstrate that Cas9 nucleases can be directed by short RNAs to induce precise cleavage at endogenous genomic loci in human and mouse cells. Cas9 can also be converted into a nicking enzyme to facilitate homology-directed repair with minimal mutagenic activity. Lastly, multiple guide sequences can be encoded into a single CRISPR array to enable simultaneous editing of several sites within the mammalian genome, demonstrating easy programmability and wide applicability of the RNA-guided nuclease technology.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            RNA-guided human genome engineering via Cas9.

            Bacteria and archaea have evolved adaptive immune defenses, termed clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems, that use short RNA to direct degradation of foreign nucleic acids. Here, we engineer the type II bacterial CRISPR system to function with custom guide RNA (gRNA) in human cells. For the endogenous AAVS1 locus, we obtained targeting rates of 10 to 25% in 293T cells, 13 to 8% in K562 cells, and 2 to 4% in induced pluripotent stem cells. We show that this process relies on CRISPR components; is sequence-specific; and, upon simultaneous introduction of multiple gRNAs, can effect multiplex editing of target loci. We also compute a genome-wide resource of ~190 K unique gRNAs targeting ~40.5% of human exons. Our results establish an RNA-guided editing tool for facile, robust, and multiplexable human genome engineering.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Using DECIPHER v2.0 to Analyze Big Biological Sequence Data in R

                Bookmark

                Author and article information

                Contributors
                michele.youd@egenesisbio.com
                wenning.qin@egenesisbio.com
                Journal
                Nature
                Nature
                Nature
                Nature Publishing Group UK (London )
                0028-0836
                1476-4687
                11 October 2023
                11 October 2023
                2023
                : 622
                : 7982
                : 393-401
                Affiliations
                [1 ]eGenesis, Cambridge, MA USA
                [2 ]GRID grid.32224.35, ISNI 0000 0004 0386 9924, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, ; Boston, MA USA
                [3 ]GRID grid.32224.35, ISNI 0000 0004 0386 9924, Department of Pathology, , Massachusetts General Hospital, Harvard Medical School, ; Boston, MA USA
                [4 ]Duke Transplant Center, Department of Surgery, Duke University Medical Center, ( https://ror.org/03njmea73) Durham, NC USA
                [5 ]GRID grid.28803.31, ISNI 0000 0001 0701 8607, Department of Surgery, Division of Transplantation, School of Medicine and Public Health, , University of Wisconsin, ; Madison, WI USA
                [6 ]GRID grid.14003.36, ISNI 0000 0001 2167 3675, Wisconsin National Primate Research Center, ; Madison, WI USA
                [7 ]Department of Animal and Dairy Science, University of Wisconsin, ( https://ror.org/01y2jtd41) Madison, WI USA
                [8 ]GRID grid.38142.3c, ISNI 000000041936754X, Department of Genetics, , Harvard Medical School, ; Boston, MA USA
                [9 ]GRID grid.38142.3c, ISNI 000000041936754X, Wyss Institute of Biologically Inspired Engineering, , Harvard University, ; Cambridge, MA USA
                Author information
                http://orcid.org/0000-0001-7950-0961
                http://orcid.org/0000-0003-3891-8581
                http://orcid.org/0000-0001-7993-6167
                http://orcid.org/0000-0001-9626-1034
                http://orcid.org/0000-0002-4493-4150
                http://orcid.org/0000-0003-1091-6074
                http://orcid.org/0000-0001-8368-1291
                http://orcid.org/0000-0002-1360-938X
                http://orcid.org/0000-0001-8528-4249
                http://orcid.org/0000-0001-5004-8959
                http://orcid.org/0000-0003-0621-3202
                http://orcid.org/0000-0001-8551-5035
                http://orcid.org/0000-0002-0605-0581
                http://orcid.org/0000-0001-8715-9134
                http://orcid.org/0000-0002-0801-7646
                http://orcid.org/0000-0002-5075-4148
                http://orcid.org/0000-0001-9028-6046
                http://orcid.org/0000-0003-3615-0994
                http://orcid.org/0000-0002-8563-5472
                http://orcid.org/0000-0002-8882-1668
                http://orcid.org/0000-0002-2762-6535
                http://orcid.org/0000-0003-3535-2076
                http://orcid.org/0000-0002-6900-4603
                http://orcid.org/0009-0001-4677-9115
                http://orcid.org/0000-0001-9168-5102
                Article
                6594
                10.1038/s41586-023-06594-4
                10567564
                37821590
                bd683d4c-7e31-421d-9357-0f8d7dae9e84
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 2 December 2022
                : 31 August 2023
                Categories
                Article
                Custom metadata
                © Springer Nature Limited 2023

                Uncategorized
                synthetic biology,preclinical research
                Uncategorized
                synthetic biology, preclinical research

                Comments

                Comment on this article